Market Access Growth Petauri has expanded its market access leadership with key hires across GPMA and Petauri Evidence, including a Vice President of Manufacturer Trade Relations and Operations and Directors in Petauri Evidence. This signals a strategic push to win larger pharma manufacturers and payers with value-based contracting, pricing optimization, and evidence-driven market access services.

Channel Strategy The February 2025 launch of a dedicated channel strategy offering indicates growing demand for go to market optimization and channel specific pricing or contracting strategies, presenting an opportunity to upsell to current clients and attract manufacturers seeking distribution channel excellence.

ACE and Evidence The ACE initiative launched January 9 2025 positions Petauri to offer integrated access insights and customer experience capabilities alongside Petauri Evidence, enabling cross-selling of market access strategy, health economics, and real world data services to life science customers.

Industry Presence Active participation in World Evidence, Pricing and Access Congress and related events demonstrates thought leadership and provides lead generation opportunities with potential clients seeking partnerships for pricing, access and HEOR programs.

Financial Position With reported revenue in the $1M to $10M range and a small, agile team, Petauri presents a cost-effective partner for mid-market life sciences firms seeking specialized market access expertise, while maintaining opportunities to scale via new offerings and strategic hires.